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63  [6] , and as with FMF, is frequently related to low-penetrance 
mutations  [6–8] . Patients with adult-onset TRAPS may be char-
acterized by a phenotype that can mimic FMF in the duration of 
inflammatory attacks, which may last  ! 1 week  [9] . In addition, 
patients with adult-onset TRAPS may present with atypical clin-
ical manifestations, such as recurrent serosal involvement of peri-
cardium as the sole clinical manifestation  [6–8] . Among these 
subjects, we recently hypothesized the criteria (positive family 
history and poor response to colchicine) for identifying patients 
for whom testing for genetic mutations of the  TNFRSF1A gene 
should be carried out  [7, 8] . In addition, with the aim of improv-
ing the genetic diagnosis in adults with suspected autoinflamma-
tory disorders, we have recently identified some variables that ap-
pear to be strongly related to the probability of detecting gene 
mutations in  MEFV and  TNFRSF1A and we have also developed 
a diagnostic score for identifying patients at high risk of carrying 
these mutations (unpublished data, paper submitted). Our score, 
since the thoracic involvement (pleural and/or pericardial) was 
included, in addition to the clinical criteria that we previously 
suggested  [7, 8] , might also represent an evidence-based guideline, 
thus assisting in the diagnostic evaluation of patients with recur-
rent fever and isolated serosal involvement, and could help iden-
tify the few patients among them who may prove to be carriers of 
mutations in ‘autoinflammatory genes’.
 In conclusion, we strongly believe that adults presenting with 
idiopathic recurrent serositis should be evaluated for mutations 
in the genes responsible for FMF and TRAPS in order to identify 
patients with FMF and TRAPS, since through lack of an appropri-
ate treatment, they may be at high risk of developing secondary 
renal amyloidosis. However, genetic testing of all patients present-
ing with a recurrent inflammatory serosal involvement might 
have low efficiency and elevated costs. Therefore, more research 
is needed in order to identify evidence-based criteria for selecting 
the patients who need to be genetically analyzed for mutations in 
the autoinflammatory genes. 
 We read with great interest the article by Lega et al.  [1] , who 
described a patient with familial Mediterranean fever (FMF) who 
had febrile episodes of right-sided pleuritis, in absence of any ex-
trathoracic complaints. The patient did not fulfill the diagnostic 
criteria for FMF  [2] , nevertheless colchicine administration led to 
the complete resolution of attacks, and genetic testing further 
strengthened the presumptive diagnosis, since the patient showed 
a homozygous M694I/M694I mutation in the  MEFV gene. The 
article by Lega et al. suggests that autoinflammatory disorders, 
mainly when the onset is in adulthood, may sometimes present 
with isolated serosal involvement. Since an increasing interest is 
currently being devoted to serositis and autoinflammatory disor-
ders  [3] , we would like to present some additional data on our 
personal experience with adult-onset autoinflammatory disor-
ders and their presentation with isolated serosal involvement oc-
curring with fever.
 To date, among monogenic periodic fever syndromes, a late 
onset of symptoms is reported both for FMF  [4] , up to the age of 
65  [5] , and for tumor necrosis factor receptor-associated periodic 
syndrome (TRAPS)  [6–8] . FMF, caused by mutations in the 
 MEFV gene, and TRAPS, caused by mutations in the  TNFRSF1A 
gene, are respectively the most common autoinflammatory reces-
sive and autosomal dominant disorders and are characterized by 
recurrent episodes of fever associated with abdominal and chest 
pain, arthralgia and/or arthritis, and cutaneous manifestations. 
Adult-onset FMF is usually related to low-penetrance mutations, 
and patients may experience milder disease, although the clinical 
manifestations are usually similar to those of younger patients, 
with the exception of arthritis and erysipelas-like erythema, 
which are significantly less frequent in adults  [3] . Disease onset in 
adulthood has been described for TRAPS as well, up to the age of 
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